Amcenestrant in combination with CDK4/6 inhibitor palbociclib demonstrates synergistic anti-tumor activity in ER plus endocrine-resistant breast cancer xenograft models

被引:1
作者
Shomali, Maysoun
Guo, Zhuyan
Cheng, Jane
Sullivan, Amy
El-Ahmad, Youssef
Sun, Fangxian
Sidhu, Sukhvinder
Lee, Joon Sang
Cai, Hui
Pollard, Jack
Debussche, Laurent
Soria, Chris
Bouaboula, Monsif
机构
关键词
D O I
10.1158/1538-7445.SABCS21-P4-02-08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-02-08
引用
收藏
页数:2
相关论文
共 50 条
[41]   Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells [J].
Sun, Chao-Yue ;
Talukder, Milton ;
Cao, Di ;
Chen, Cun-Wu .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[42]   Anti-tumor activity of CDK2 inhibitor BLU-222 in combination with CDK4/6 inhibitors for overcoming resistance in HR positive and triple negative metastatic breast cancers models [J].
Luo, Linjie ;
Wang, Yan ;
Bui, Tuyen ;
Li, Mi ;
Kim, Serena ;
Navarro-Yepes, Juliana ;
Kettner, Nicole M. ;
Tripathy, Debasish ;
Hunt, Kelly K. ;
Faia, Kerrie ;
Keyomarsi, Khandan .
CANCER RESEARCH, 2024, 84 (06)
[43]   Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer [J].
Kase, Adam M. ;
Gleba, Justyna ;
Miller, James L. ;
Miller, Erin ;
Petit, Joachim ;
Barrett, Michael T. ;
Zhou, Yumei ;
Parent, Ephraim E. ;
Cai, Hancheng ;
Knight, Joshua A. ;
Orme, Jacob ;
Reynolds, Jordan ;
Durham, William F. ;
Metz, Thomas M. ;
Meurice, Nathalie ;
Edenfield, Brandy ;
Demirer, Aylin Alasonyalilar ;
Bilgili, Ahmet ;
Hickman, Peyton G. ;
Pawlush, Matthew L. ;
Marlow, Laura ;
Wickland, Daniel P. ;
Tan, Winston ;
Copland III, John A. .
MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06) :823-835
[44]   The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER plus breast cancer [J].
Bean, Jennifer R. ;
Hosford, Sarah R. ;
Symonds, Lynn K. ;
Owens, Philip ;
Dillon, Lloye M. ;
Yang, Wei ;
Shee, Kevin ;
Schwartz, Gary N. ;
Marotti, Jonathan D. ;
Muller, Kristen E. ;
Rosenkranz, Kari M. ;
Barth, Richard J. ;
Chen, Vivian S. ;
Agarwal, Veena R. ;
Miller, Todd W. .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (01) :69-79
[45]   ARTS-023: a potent and selective CDK4 Inhibitor demonstrating antitumor activity in preclinical ER plus breast cancer models [J].
Guo, Yali ;
Chen, Jinhong ;
Schomer, Nathan ;
Liang, Jiaqi ;
Zhou, Tingru ;
Liu, Xipan ;
Liang, Wenheng ;
Pang, Wei ;
Fu, Jia ;
Zhang, Xiaobin ;
Cheng, Dai ;
Campbell, John ;
Ji, Tao ;
Li, Fang ;
Chen, Yaoyu ;
Sheng, Qing .
CANCER RESEARCH, 2025, 85 (08)
[46]   Investigating anti-tumor immunity with CDK4/6 inhibition in triple negative breast cancer. [J].
Guo, Qiuchen ;
Spasic, Milos ;
Goreczny, Gregory ;
Maynard, Adam ;
McAllister, Sandra .
CANCER RESEARCH, 2021, 81 (13)
[47]   Safety and Efficacy of Palbociclib (CDK4/6 inhibitor) and Radiotherapy in Metastatic Breast Cancer Patients: Initial Results of a Novel Combination [J].
Chowdhary, M. ;
Sen, N. ;
Chowdhary, A. ;
Usha, L. ;
Cobleigh, M. ;
Wang, D. ;
Patel, K. ;
Barry, P. N., Jr. ;
Rao, R. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01) :E2-E2
[48]   Bromodomain inhibition reduces CDK6 expression and reverses CDK4/6 inhibitor resistance in ER plus breast cancer. [J].
Liu, Renyan ;
Pantelidou, Constantia ;
Jadhav, Heta ;
Shapiro, Geoffrey .
CANCER RESEARCH, 2022, 82 (12)
[49]   An oral and selective CDK7 inhibitor demonstrates substantial anti-tumor effect in breast and ovarian cancer models [J].
Hu, S. ;
Marineau, J. ;
Bradley, M. ;
Hamman, K. ;
Alnemy, S. ;
Smith, D. ;
Carulli, J. ;
Chuaqui, C. .
EUROPEAN JOURNAL OF CANCER, 2018, 103 :E39-E40
[50]   PRMT5 is an actionable target in CDK4/6 inhibitor-resistant ER plus /Rb-deficient breast cancer [J].
Lin, Chang-Ching ;
Chang, Tsung-Cheng ;
Wang, Yunguan ;
Zhang, Yanfeng ;
Lemoff, Andrew ;
Fang, Yisheng V. ;
Zhang, He ;
Ye, Dan ;
Soria-Bretones, Isabel ;
Servetto, Alberto ;
Lee, Kyung-Min ;
Luo, Xuemei ;
Otto, Joseph J. ;
Akamatsu, Hiroaki ;
Cescon, David W. ;
Xu, Lin ;
Xie, Yang ;
Mendell, Joshua T. ;
Hanker, Ariella B. ;
Arteaga, Carlos L. .
CANCER RESEARCH, 2023, 83 (07)